↓ Skip to main content

Generation and Characterization of a Diabody Targeting the αvβ6 Integrin

Overview of attention for article published in PLOS ONE, September 2013
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
35 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Generation and Characterization of a Diabody Targeting the αvβ6 Integrin
Published in
PLOS ONE, September 2013
DOI 10.1371/journal.pone.0073260
Pubmed ID
Authors

Heide Kogelberg, Enrique Miranda, Jerome Burnet, David Ellison, Berend Tolner, Julie Foster, Carmen Picón, Gareth J. Thomas, Tim Meyer, John F. Marshall, Stephen J. Mather, Kerry Chester

Abstract

The αvβ6 integrin is up-regulated in cancer and wound healing but it is not generally expressed in healthy adult tissue. There is increasing evidence that it has a role in cancer progression and will be a useful target for antibody-directed cancer therapies. We report a novel recombinant diabody antibody fragment that targets specifically αvβ6 and blocks its function. The diabody was engineered with a C-terminal hexahistidine tag (His tag), expressed in Pichia pastoris and purified by IMAC. Surface plasmon resonance (SPR) analysis of the purified diabody showed affinity in the nanomolar range. Pre-treatment of αvβ6-expressing cells with the diabody resulted in a reduction of cell migration and adhesion to LAP, demonstrating biological function-blocking activity. After radio-labeling, using the His-tag for site-specific attachment of (99m)Tc, the diabody retained affinity and targeted specifically to αvβ6-expressing tumors in mice bearing isogenic αvβ6 +/- xenografts. Furthermore, the diabody was specifically internalized into αvβ6-expressing cells, indicating warhead targeting potential. Our results indicate that the new αvβ6 diabody has a range of potential applications in imaging, function blocking or targeted delivery/internalization of therapeutic agents.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Germany 1 3%
Unknown 33 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 29%
Researcher 5 14%
Student > Ph. D. Student 5 14%
Student > Bachelor 4 11%
Student > Doctoral Student 2 6%
Other 3 9%
Unknown 6 17%
Readers by discipline Count As %
Agricultural and Biological Sciences 11 31%
Chemistry 7 20%
Biochemistry, Genetics and Molecular Biology 5 14%
Medicine and Dentistry 2 6%
Unspecified 1 3%
Other 4 11%
Unknown 5 14%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 September 2013.
All research outputs
#20,200,843
of 22,719,618 outputs
Outputs from PLOS ONE
#173,077
of 193,931 outputs
Outputs of similar age
#172,365
of 196,871 outputs
Outputs of similar age from PLOS ONE
#4,375
of 5,049 outputs
Altmetric has tracked 22,719,618 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 193,931 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 196,871 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 5,049 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.